The dominance of autologous CAR T-cell therapy in the early years of cell-based immunotherapy came with significant logistical and economic hurdles, including high manufacturing costs, long turnaround times, and the risk of cytokine release syndrome (CRS). **Natural Killer (NK) cell therapeutics** are emerging as a potentially superior alternative, particularly due to their capability to be...
1
0 Commentarios
0 Acciones
209 Views
0 Vista previa
Market Overview
The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033).
The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...
0 Commentarios
0 Acciones
400 Views
0 Vista previa
فارسی
English
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Arabic